At baseline, both hs‐CRP and IL‐6 were significantly higher in patients with PAD (hs‐CRP: PAD 3.7±0.9 versus healthy 0.6±0.1 [P=0.004]; IL‐6: PAD 5.1±1.4 versus healthy 1.1±0.2 [P=0.011]). Here, MAP3K14 is linked to peripheral arterial disease.